Ep. 133: Nina Deka: Healthcare Technology Still In Early Stages Of Disruption
Investing With IBD
00:00
Dexcom
A dex com. Now, this is in the diabedes. We do have a lot of these a situations where you've got these chronic diseases that require a another level of monitoring. A thermo, ou're scientific a ow the largest c d m o through the requisition of pthd. That's t m o a's the ticker similar on that. And there's other companies that are like that too. So let's maybe turn our attention to another stock.
Transcript
Play full episode
